SCHEMBL21855732

SCHEMBL21855732

COC(=O)CCSc1ccnc(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 1/20 0.43
▸ GSTM2 P28161 1/20 0.43
▸ KMT2A Q03164 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ PRNP P04156 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ DYRK1A Q13627 6/20 0.39
▸ CXCR1 P25024 1/20 0.39
▸ CXCR2 P25025 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ PTGS1 P23219 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29506065 1.00 GSTP1 (0.43) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL18320486 0.86 KMT2A (0.44) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL21852192 0.86 GSTP1 (0.42) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL29603922 0.86 KMT2A (0.44) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL18319841 0.78 KMT2A (0.45) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL29506060 0.78 KMT2A (0.45) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL18320494 0.76 KMT2A (0.43) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL21855915 0.76 CXCR1 (0.42) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL19785098 0.76 KMT2A (0.43) GSTP1GSTM2KMT2APOLBPRNP
SCHEMBL22303101 0.76 RXFP1 (0.52) GSTP1GSTM2KMT2APOLBPRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2025-02-27 — — US disclosed
US-12187721-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2025-01-07 — — US disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
CN-114341124-A Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2022-04-12 — — CN disclosed
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2021-12-09 — — US disclosed
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2021-12-09 — — US disclosed
WO-2020081848-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-04-23 — — WO disclosed
WO-2020081848-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C GSTP1 1370/4885GSTM2 2265/4885KMT2A 2301/4885
US-12187721-B2 Protein tyrosine phosphatase inhibitors PPM1A, PTP4A1, PPP5C GSTP1 1322/4885GSTM2 2316/4885KMT2A 2176/4885
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PTP4A1, PPP5C GSTP1 1322/4885GSTM2 2316/4885KMT2A 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback